Literature DB >> 3567304

Approximately optimal one-parameter boundaries for group sequential trials.

S K Wang, A A Tsiatis.   

Abstract

We present a class of group sequential tests, indexed by a single parameter, that yields approximately optimal results. We also provide tables of key values to help in the design of group sequential tests that meet selected specifications.

Mesh：

Year:  1987        PMID： 3567304

Source DB:  PubMed          Journal:  Biometrics        ISSN： 0006-341X            Impact factor:   2.571


  44 in total

1.  Interim analyses and sequential designs in phase III studies.

Authors:  S Todd; A Whitehead; N Stallard; J Whitehead
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

2.  Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial.

Authors:  Eileen M Bulger; Susanne May; Karen J Brasel; Martin Schreiber; Jeffrey D Kerby; Samuel A Tisherman; Craig Newgard; Arthur Slutsky; Raul Coimbra; Scott Emerson; Joseph P Minei; Berit Bardarson; Peter Kudenchuk; Andrew Baker; Jim Christenson; Ahamed Idris; Daniel Davis; Timothy C Fabian; Tom P Aufderheide; Clifton Callaway; Carolyn Williams; Jane Banek; Christian Vaillancourt; Rardi van Heest; George Sopko; J Steven Hata; David B Hoyt
Journal:  JAMA       Date:  2010-10-06       Impact factor: 56.272

3.  Opiate sparing effect of fixed combination of diclophenac and orphenadrine after unilateral total hip arthroplasty: A double-blind, randomized, placebo-controlled, multi-centre clinical trial.

Authors:  Hans Gombotz; Regina Lochner; Rudolf Sigl; Johann Blasl; Günther Herzer; Helmut Trimmel
Journal:  Wien Med Wochenschr       Date:  2010-10-08

4.  Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests.

Authors:  John A Kairalla; Keith E Muller; Christopher S Coffey
Journal:  Commun Stat Theory Methods       Date:  2010-12-01       Impact factor: 0.893

5.  Testing a primary and a secondary endpoint in a group sequential design.

Authors:  Ajit C Tamhane; Cyrus R Mehta; Lingyun Liu
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

6.  Adaptive clinical trial designs in oncology.

Authors:  Yong Zang; J Jack Lee
Journal:  Chin Clin Oncol       Date:  2014-12

7.  Incorporating biomarkers to improve statistical power of immunotherapeutic neoadjuvant clinical trials in patients with triple-negative breast cancer.

Authors:  Feng Gao; Guoqiao Wang; Jingqin Luo; Jingxia Liu; Ling Chen; Chengjie Xiong
Journal:  Stat Biopharm Res       Date:  2019-04-18       Impact factor: 1.452

8.  Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol.

Authors:  Arthur J Moss; Mary W Brown; David S Cannom; James P Daubert; Mark Estes; Elyse Foster; Henry M Greenberg; W Jackson Hall; Steven L Higgins; Helmut Klein; Mark Pfeffer; David Wilber; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

9.  A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs.

Authors:  Sophie I E Knahl; Benjamin Lang; Frank Fleischer; Meinhard Kieser
Journal:  Eur J Clin Pharmacol       Date:  2018-01-23       Impact factor: 2.953

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.